NASDAQ:NVCN - Neovasc Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $0.6501 +0.01 (+1.56 %) (As of 02/22/2019 04:00 PM ET)Previous Close$0.6501Today's Range$0.6399 - $0.6652-Week Range$0.43 - $31.00Volume625,619 shsAverage Volume924,301 shsMarket Capitalization$18.22 millionP/E RatioN/ADividend YieldN/ABeta1.74 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Neovasc Inc., a specialty medical device company, develops, manufactures, and markets cardiovascular devices worldwide. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company also provides Peripatch tissue products. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada. Receive NVCN News and Ratings via Email Sign-up to receive the latest news and ratings for NVCN and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:NVCN Previous Symbol CUSIPN/A CIK1399708 Webwww.neovasc.com Phone604-270-4344Debt Debt-to-Equity RatioN/A Current Ratio4.30 Quick Ratio4.25Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$5.39 million Price / Sales3.38 Cash FlowN/A Price / Cash FlowN/A Book Value($46.21) per share Price / Book-0.01Profitability EPS (Most Recent Fiscal Year)($37.00) Net Income$-22,900,000.00 Net Margins-5,024.90% Return on EquityN/A Return on Assets-177.90%Miscellaneous Employees110 Outstanding Shares28,020,000Market Cap$18.22 million Next Earnings Date3/27/2019 (Estimated) OptionableNot Optionable Neovasc (NASDAQ:NVCN) Frequently Asked Questions What is Neovasc's stock symbol? Neovasc trades on the NASDAQ under the ticker symbol "NVCN." When did Neovasc's stock split? How did Neovasc's stock split work? Neovasc shares reverse split before market open on Friday, September 21st 2018. The 1-100 reverse split was announced on Tuesday, September 11th 2018. The number of shares owned by shareholders was adjusted after the market closes on Thursday, September 20th 2018. An investor that had 100 shares of Neovasc stock prior to the reverse split would have 1 shares after the split. How were Neovasc's earnings last quarter? Neovasc Inc (NASDAQ:NVCN) posted its earnings results on Tuesday, March, 29th. The medical equipment provider reported ($1,100.00) earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of ($1,500.00) by $400.00. The medical equipment provider had revenue of $2.24 million for the quarter, compared to the consensus estimate of $3.26 million. View Neovasc's Earnings History. When is Neovasc's next earnings date? Neovasc is scheduled to release their next quarterly earnings announcement on Wednesday, March 27th 2019. View Earnings Estimates for Neovasc. What price target have analysts set for NVCN? 2 Wall Street analysts have issued twelve-month price objectives for Neovasc's shares. Their predictions range from $5,000.00 to $20,000.00. On average, they expect Neovasc's stock price to reach $12,500.00 in the next twelve months. This suggests a possible upside of 1,922,681.1% from the stock's current price. View Analyst Price Targets for Neovasc. What is the consensus analysts' recommendation for Neovasc? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neovasc in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Neovasc. Has Neovasc been receiving favorable news coverage? Media stories about NVCN stock have trended somewhat negative on Saturday, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative news coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Neovasc earned a media sentiment score of -1.5 on InfoTrie's scale. They also gave media headlines about the medical equipment provider a news buzz of 1.0 out of 10, meaning that recent news coverage is extremely unlikely to have an effect on the company's share price in the immediate future. Who are some of Neovasc's key competitors? Some companies that are related to Neovasc include Spectral Medical (EDTXF), CAS Medical Systems (CASM), Motus GI (MOTS), Pro-Dex (PDEX), Alphatec (ATEC), Arch Therapeutics (ARTH), Endologix (ELGX), Repro-Med Systems (REPR), Obalon Therapeutics (OBLN), AIT Therapeutics (AITB), Restoration Robotics (HAIR), Nephros (NEPH), Interpace Diagnostics Group (IDXG), PAVmed (PAVM) and SANUWAVE Health (SNWV). What other stocks do shareholders of Neovasc own? Based on aggregate information from My MarketBeat watchlists, some companies that other Neovasc investors own include Biopharmx (BPMX), Synergy Pharmaceuticals (SGYP), Allstate (ALL), Amicus Therapeutics (FOLD), 22nd Century Group (XXII), SCYNEXIS (SCYX), Genocea Biosciences (GNCA), Gevo (GEVO), Novavax (NVAX) and Exelixis (EXEL). Who are Neovasc's key executives? Neovasc's management team includes the folowing people: Mr. Fredericus A. Colen, Pres & CEO (Age 66)Mr. Christopher Clark BA (Honours), PgD, CA, CFO & Corp. Sec. (Age 47)Ms. Vicki Bebeau, VP of Clinical & Regulatory Affairs (Age 68)Mr. Randy Lane, VP of New Concept Devel. & Intellectual Property (Age 46)Mr. Alexei J. Marko, Advisor & Director (Age 50) Who are Neovasc's major shareholders? Neovasc's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Virtu Financial LLC (0.27%). Which institutional investors are buying Neovasc stock? NVCN stock was bought by a variety of institutional investors in the last quarter, including Virtu Financial LLC. How do I buy shares of Neovasc? Shares of NVCN can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Neovasc's stock price today? One share of NVCN stock can currently be purchased for approximately $0.6501. How big of a company is Neovasc? Neovasc has a market capitalization of $18.22 million and generates $5.39 million in revenue each year. The medical equipment provider earns $-22,900,000.00 in net income (profit) each year or ($37.00) on an earnings per share basis. Neovasc employs 110 workers across the globe. What is Neovasc's official website? The official website for Neovasc is http://www.neovasc.com. How can I contact Neovasc? Neovasc's mailing address is Suite 5138 - 13562 Maycrest Way, Richmond A1, V6V 2J7. The medical equipment provider can be reached via phone at 604-270-4344 or via email at [email protected] MarketBeat Community Rating for Neovasc (NASDAQ NVCN)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 284 (Vote Outperform)Underperform Votes: 216 (Vote Underperform)Total Votes: 500MarketBeat's community ratings are surveys of what our community members think about Neovasc and other stocks. Vote "Outperform" if you believe NVCN will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NVCN will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/23/2019 by MarketBeat.com StaffFeatured Article: What are catch-up contributions?